seeking price quotations from the minimum two specialist homecare companies (HCC; companies A and B) for provision of HPN and forwarding to the PCT with a letter requesting written authorization.
At one year, forty-two patients continue with their HPN, four have stopped HPN (one by another hospital, three after restorative surgery) and four died post-discharge.
Sixty percent of patients referred for assessment for HPN were discharged with HPN. For those undergoing HPN therapy, the funding process is prolonged. While there may be small differences between the two HCC used, these do not affect length of stay. The greatest influence on length of stay is the patient's clinical condition and recovery, particularly if specialist nursing is required at home. These data may be important for centres planning to develop services for HPN.
